Last update 11 Jul 2024

Rituximab biosimilar (Innovent Biologics)

Overview

Basic Info

Drug Type
Biosimilar, Monoclonal antibody
Synonyms
HALPRYZA, Rituximab biosimilar
+ [1]
Target
Mechanism
CD20 inhibitors(B-lymphocyte antigen CD20 inhibitors), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects), CD20-directed cytolytic effects
+ [1]
Inactive Organization-
Drug Highest PhaseApproved
RegulationPriority Review (CN)
Login to view First Approval Timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Chronic Lymphocytic Leukemia
CN
30 Sep 2020
Diffuse Large B-Cell Lymphoma
CN
30 Sep 2020
Follicular Lymphoma
CN
30 Sep 2020
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Refractory Follicular LymphomaPhase 2-28 Jul 2023
CD20 positive B-Cell LymphomaPhase 1
CN
13 Dec 2016
CD20 positive Diffuse Large B-Cell LymphomaPhase 1
CN
22 Aug 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
419
(oekwbmsbrz) = xsveawhzvc fbclsfmqyt (ztnexdszxh )
Positive
09 Mar 2021
(oekwbmsbrz) = ltkdqivexb fbclsfmqyt (ztnexdszxh )
Phase 3
181
(iyhwigcvgq) = The geometric mean ratios and 90% CIs of AUC0-inf between IBI301 and rituximab groups are all within the predetermined bioequivalence range (80.00% ~125.00%), which shown bioequivalent of IBI301 with the original drug. ckbqrivpcm (mteppehasj )
Similar
20 Sep 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free